✦ LIBER ✦

Phase III trial of bolus 5-fluorouracil (5-FU)/folinic acid (FA) (MAYO) vs. weekly oxaliplatin (OXA) plus high dose 24h 5-FU infusion/FA in patients with advanced colorectal cancer (CRC)

✍ Scribed by A. Grothey; T. Buechele; H. Kroening; K. Ridwelski; P. Reichardt; A. Kretzschmar; M. Clemens; H.J. Schmoll

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose chronomodulated infusion of 5-

✍ Edmondo Terzoli; Carlo Garufi; Albina Rita Zappalà; Barbara Vanni; Patrizia Pugl 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 217 KB

Randomized phase II study of weekly 24 h

✍ U. Vanhoefer; T. Wagner; M. Lutz; E. Van Cutsem; B. Nordlinger; S. Reuse; B. Bar 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 189 KB

754 5-FU/FA IV bolus therapy vs weekly h

✍ H.J. Weh; M. Hoffknecht; P. Hölzer; D. Braumann; R. Hoffman; H.J. Gellermann; K. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Plasma and salivary pharmacokinetics of

✍ J.M Joulia; F Pinguet; M Ychou; J Duffour; C Astre; F Bressolle 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Factors predicting for efficacy of oxali

✍ M.A Bensmaı̈ne; A de Gramont; S Brienza; M Marty; F Lévi; M Ducreux; E François; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 155 KB

597 ORAL A randomised phase III multicen

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB